5-Azaspiro[2.4]heptan-7-amine, 5-(3-fluoropropyl)-N-[6-[(1S,3R)-2,3,4,9-tetrahydro-3-methyl-2-(2,2,2-trifluoroethyl)-1H-pyrido[3,4-b]indol-1-yl]-3-pyridinyl]-, (7S)-

Request For Quotation

5-Azaspiro[2.4]heptan-7-amine, 5-(3-fluoropropyl)-N-[6-[(1S,3R)-2,3,4,9-tetrahydro-3-methyl-2-(2,2,2-trifluoroethyl)-1H-pyrido[3,4-b]indol-1-yl]-3-pyridinyl]-, (7S)- manufacturers
5-Azaspiro[2.4]heptan-7-amine, 5-(3-fluoropropyl)-N-[6-[(1S,3R)-2,3,4,9-tetrahydro-3-methyl-2-(2,2,2-trifluoroethyl)-1H-pyrido[3,4-b]indol-1-yl]-3-pyridinyl]-, (7S)- Basic information
Product Name:5-Azaspiro[2.4]heptan-7-amine, 5-(3-fluoropropyl)-N-[6-[(1S,3R)-2,3,4,9-tetrahydro-3-methyl-2-(2,2,2-trifluoroethyl)-1H-pyrido[3,4-b]indol-1-yl]-3-pyridinyl]-, (7S)-
Synonyms:5-Azaspiro[2.4]heptan-7-amine, 5-(3-fluoropropyl)-N-[6-[(1S,3R)-2,3,4,9-tetrahydro-3-methyl-2-(2,2,2-trifluoroethyl)-1H-pyrido[3,4-b]indol-1-yl]-3-pyridinyl]-, (7S)-
CAS:2751609-45-5
MF:C28H33F4N5
MW:515.59
EINECS:
Product Categories:
Mol File:2751609-45-5.mol
5-Azaspiro[2.4]heptan-7-amine, 5-(3-fluoropropyl)-N-[6-[(1S,3R)-2,3,4,9-tetrahydro-3-methyl-2-(2,2,2-trifluoroethyl)-1H-pyrido[3,4-b]indol-1-yl]-3-pyridinyl]-, (7S)- Structure
5-Azaspiro[2.4]heptan-7-amine, 5-(3-fluoropropyl)-N-[6-[(1S,3R)-2,3,4,9-tetrahydro-3-methyl-2-(2,2,2-trifluoroethyl)-1H-pyrido[3,4-b]indol-1-yl]-3-pyridinyl]-, (7S)- Chemical Properties
Boiling point 616.5±55.0 °C(Predicted)
density 1.33±0.1 g/cm3(Predicted)
pka17.09±0.60(Predicted)
Safety Information
MSDS Information
5-Azaspiro[2.4]heptan-7-amine, 5-(3-fluoropropyl)-N-[6-[(1S,3R)-2,3,4,9-tetrahydro-3-methyl-2-(2,2,2-trifluoroethyl)-1H-pyrido[3,4-b]indol-1-yl]-3-pyridinyl]-, (7S)- Usage And Synthesis
UsesEstrogen receptor antagonist 1 is a selective estrogen receptor antagonist. Estrogen (E2) and estrogen alpha receptor (ERα) are important drivers of breast cancer development. Estrogen receptor antagonist 1 has the potential for the research of breast cancer diseases (extracted from patent WO2021249533A1, compound 4)[1].
References[1] Zhang Yan, et al. Estrogen receptor modulator compounds and their uses. Patent WO2021249533A1.
5-Azaspiro[2.4]heptan-7-amine, 5-(3-fluoropropyl)-N-[6-[(1S,3R)-2,3,4,9-tetrahydro-3-methyl-2-(2,2,2-trifluoroethyl)-1H-pyrido[3,4-b]indol-1-yl]-3-pyridinyl]-, (7S)- Preparation Products And Raw materials
Tag:5-Azaspiro[2.4]heptan-7-amine, 5-(3-fluoropropyl)-N-[6-[(1S,3R)-2,3,4,9-tetrahydro-3-methyl-2-(2,2,2-trifluoroethyl)-1H-pyrido[3,4-b]indol-1-yl]-3-pyridinyl]-, (7S)-(2751609-45-5) Related Product Information
27-Hydroxycholesterol Fulvestrant Estrone 3-sulfate sodium salt Ethinyl Estradiol β-Estradiol 2,3-Bis(4-hydroxyphenyl)-propionitrile